Newsroom

NEW YORK--(BUSINESS WIRE)--DC Administration Services, Inc. (DCAS) souhaiterait inviter tous les membres de l'ISDA intéressés à poser leur candidature pour devenir membre des Comités de détermination des produits dérivés de crédit. Chaque région concernée est couverte par un comité de détermination distinct. Les membres de l'ISDA peuvent candidater en tant que membre courtier ou membre non courtier (selon le cas). Les parties souhaitant candidater doivent examiner attentivement les conditions e...

SAN CLEMENTE, California--(BUSINESS WIRE)--Angelalign Technology Inc. (6699.HK) («Angel» o la «empresa») ha publicado sus resultados financieros correspondientes al ejercicio fiscal 2025. Durante el periodo analizado, la empresa siguió obteniendo buenos resultados tanto en el mercado internacional como en el chino. El volumen total de casos fue de 532 400, lo que supone un aumento del 48,1 %; los ingresos ascendieron a 370,3 millones de dólares, lo que supone un aumento del 37,8 %; y el benefic...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ:IBRX) securities during the period of January 19, 2026 through March 24, 2026, inclusive (“the Class Period”). If you suffered a loss on your ImmunityBio investments, you have until May 26, 2026 to request lead plaintiff appointment. For more information: [CONTACT THE FIRM IF YOU SUFFERE...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Angelalign Technology Inc. (6699.HK) (“Angel” of het “Bedrijf") heeft de financiële resultaten voor boekjaar 2025 bekendgemaakt. In de loop van de verslagperiode bleef het bedrijf het uitstekend doen, zowel op de wereldwijde markt als op de Chinese markt. Het totale casevolume bedroeg 532.400, een stijging met 48,1%, de omzet bedroeg USD 370,3 miljoen, een stijging met 37,8%, en de gecorrigeerde nettowinst bedroeg USD 43,8 miljoen, een stijging met 63,0%....

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today provided a corporate update following the filing of its 10-K on Friday, March 27, 2026, which reported financial results for the fourth quarter and year ended December 31, 2025. CEO Commentary: “The year 2025 was a year of important scientific progress for En...

WASHINGTON--(BUSINESS WIRE)--The latest GAO report confirms what CCAGW has long warned: Since CMMI was established in Obamacare in 2010, it has squandered the taxpayer’s money....

WASHINGTON--(BUSINESS WIRE)--The Foundation for the Development of Western Syria (the “Foundation”) expresses its strongest condemnation of a series of extremist attacks and coordinated movements witnessed across several Syrian provinces. These developments represent a dangerous escalation that threatens Syria’s social fabric and specifically targets the country’s indigenous Christian community. I. Attack on the City of Al-Suqaylabiyah According to field sources, a coordinated attack was carrie...

PONTIAC, Mich.--(BUSINESS WIRE)--UWMC today issued the following statement regarding its proposal to acquire TWO. “The actions by TWO’s management and board do not reflect the best interests of their shareholders. The same team that had to settle a $375 million lawsuit this past summer is at it again. TWO’s decision appears to be driven more by ego, than by sound judgment. The deal for us was a strategy to acquire their servicing book, not their operations, as ultimately there are no operationa...

IRVINE, California--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" o l'"Azienda"), un'organizzazione di servizi di gestione che opera in un ampio ventaglio di attività di franchising in diversi campi medici, ha annunciato oggi i propri risultati finanziari per il quarto trimestre dell'esercizio fiscale 2025 (i tre mesi conclusisi il 31 dicembre 2025) e per l'intero esercizio fiscale 2025 (i dodici mesi conclusisi il 31 dicembre 2025). Punti salienti del qu...

IRVINE, California--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) («SBC Medical» o la «Empresa»), una organización de servicios de gestión que opera una amplia cartera de franquicias en diversos campos médicos, ha anunciado hoy sus resultados financieros correspondientes al cuarto trimestre del ejercicio fiscal 2025 (tres meses concluidos el 31 de diciembre de 2025) y al ejercicio fiscal completo 2025 (doce meses finalizados el 31 de diciembre de 2025). Aspectos destaca...